PF-Atlas › Clinical Trials › NCT02370784

Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma

atorvastatin · Phase 2

Registry ID

NCT02370784

Phase

Phase 2

Status

Completed

Drug / intervention

atorvastatin

Sponsor

Robyn T. Domsic, MD, MPH

Start

2015-02

About this trial

atorvastatin is evaluated in NCT02370784, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Robyn T. Domsic, MD, MPH. Current status: Completed.

View NCT02370784 on ClinicalTrials.gov →

Explore related

All atorvastatin trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT02370784 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.